Search

• Fate of nine tri-OPFRs in sludge was studied in a WWTP in Beijing, China. • Sludge contained high concentrations of tri-OPFRs (971.48–1,702.22 ng/g). • Mass flow of tri-OPFRs showed seasonal decreases. • The dehydration unit removed the most tri-OPFRs during sludge treatment. • Ecological risk of OPFRs in treated sludge was reduced. Organophosphate flame retardants (OPFRs) are emerging environmental pollutants that cause endocrine disruption, neurotoxicity, and reproductive toxicity. Sewage sludge is an important source of tri-OPFRs that are released into the environment. The occurrence, distribution, and ecological risk of OPFRs in the full-scale "Cambi® thermal hydrolysis (TH) + advanced anaerobic digestion (AAD) + plate-frame pressure filtration" sludge treatment process is closely related to the application of sewage sludge. We tested sludge samples from a wastewater treatment plant in Beijing, China. Nine tri-OPFRs were detected in the sludge samples collected at different treatment units during four seasons. The ΣOPFRs decreased from 1,742.65–2,579.68 ng/g to 971.48–1,702.22 ng/g. The mass flow of tri-OPFRs in treated sludge decreased by 61.4%, 48.9%, 42.4%, and 63.9% in spring, summer, autumn and winter, respectively, effectively reducing the corresponding ecological risk. The ecological risk of tri-OPFRs in sludge in forestland utilization mainly lies in chlorinated tri-OPFRs, especially TCPP and TCEP. No >42.20 t/hm2 of sludge could be used continuously for one year to prevent tri-OPFRs from exceeding the low ecological risk level, indicating that the current commonly applied proportion of sludge (1.6–30 t/hm2) will likely not raise the ecological risk of tri-OPFRs. [ABSTRACT FROM AUTHOR]

The emergence of extensively drug-resistant tuberculosis (XDR-TB) in China is a great threat to TB control. To determine the molecular characterisation of XDR-TB isolates from China and the correlations between specific drug resistance-associated mutations and different genotype strains, 58 XDR-TB isolates were sequenced in eight drug loci, including katG , inhA , oxyR–ahpC intergenic region, rpoB , eis , rrs , gyrA and gyrB , and were genotyped using spoligotyping and analysis of the noise transfer function region. Compared with the phenotypic data, the sensitivities and specificities for DNA sequencing were 87.9% and 100.0% for isoniazid (INH), 91.4% and 98.3% for rifampicin (RIF), 60.4% and 100.0% for kanamycin (KAN) and 81.0% and 100.0% for ofloxacin (OFX), respectively. A combination of eight drug loci predicted XDR-TB phenotypes with 53.4% sensitivity (31/58 isolates) and 100.0% specificity. The most frequent mutations among these XDR-TB isolates were katG 315 and inhA -15 (for INH), 531, 526 and 516 in rpoB (for RIF), rrs 1401 and eis –10 (for KAN) and 94, 90 and 91 in gyrA (for OFX). Also, among these XDR-TB isolates, 44 (75.9%) were identified as Beijing genotype strain, of which 31 (70.5%) belonged to the modern Beijing sublineage. inhA -8, rpoB 526 and rpoB 531 mutations demonstrated significant statistical associations with ancient and modern Beijing family sublineage ( P < 0.05). However, Beijing and non-Beijing genotypes showed no association with specific resistance-conferring mutations. These results will be helpful in designing new molecular biology-based techniques to diagnose XDR-TB in China. [ABSTRACT FROM AUTHOR]